Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:44 PM
Ignite Modification Date:
2025-12-24 @ 2:44 PM
NCT ID:
NCT01353859
Eligibility Criteria:
Inclusion Criteria:
* Adult patients, \>/= 18 years of age
* Moderate to severe active rheumatoid arthritis (RA) of \>/= 6 months duration
* Prior treatment with DMARDs for \>/= 12 weeks (at stable dose for \>/= 8 weeks)
* Inadequate clinical response to stable dose of non-biologic DMARD (either single or in combination)
Exclusion Criteria:
* Major surgery (including joint surgery) within 8 weeks prior to screening or planned major surgery within 6 months following enrollment
* Autoimmune disease other than RA
* History of or current inflammatory joint disease other than RA
* Previous treatment with any biologic drug that is used in the treatment of RA
* Intra-articular or parenteral corticosteroids within 6 weeks prior to baseline
* Impaired liver, renal or hematologic function
* Active current or history of recurrent infection
* History of or currently active primary or secondary immunodeficiency
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01353859
Study Brief:
Protocol Section:
NCT01353859